Assay of Human Chorionic Gonadotropin in Urine of Athletes and Evaluation of Assay Kit Performance

운동선수들의 뇨 중 Human Chorionic Gonadotropin 분석 및 분석킷트 평가

  • 최명자 (한국과학기술연구원 생체대사연구센터) ;
  • 이정란 (한국과학기술연구원 생체대사연구센터) ;
  • 김명수 (한국과학기술연구원 생체대사연구센터)
  • Published : 2002.09.01


Special attention has been paid to human chorionic gonadotropin (hCG) for athlete doping control because it stimulates the endogenous production of testosterone and epitestosterone without increasing the T/E ratio which is a doping indicator for the exogenous administration of testosterone. Even though the IOC banned the use of hCG, a detection method has not been decided upon since there are a variety of immunoassay kits available on the market. We evaluated three kits in terms of their performance characteristics. The assay value of the control sample varied depending on the kit, resulting in 198 mIU/ml for the MAIA kit, 172mIU/ml for the IRMA kit, and 143 mIU/ml for the MEIA kit. Considering the IOC inter-lab distribution of results(55-312 mIU/ml) using 27 different kits and the mean value (178$\pm$56 mIU/ml), all three kits are within the range of -15.8% - +5.6% of the mean value, which proves them useful for the hCG assay. The MEIA kit resulted in lower hCG values because it detects only intact hCG molecules, in contrast to the other two kits which detect intact hCG and -hCG together. However, it is suitable for screening purposes because of its advantage of being an automated system. When 123 urine samples of athletes were analyzed in 22 batches using this system, the variation of control values fell within $\pm$ 10% of the mean values, and an specimens tested negative with hCG values less than the detection limit of 2 mIU/ml.



  1. Alfthan, H., Haglund, C., Dabek, J. and Stenman, U-H. (1992). Concentrations of hCG, $\beta$hCG and c$\beta$hCG in serum and urine of non-pregnant wome and men. Clin. Chem,. 38, 1981-1987
  2. Choi, M. J., Choe, I. S., Kang, H., Lee, J. S. and Chung, T. W. (1991). Simple enzyme immunoassay for the simultaneous measurement of wholechoriogondotropin molecules and its free $\beta$-subunits in sera of abnormal pregnancies and tumor of the reproductive system, Clin. Chem., 37 (5), 673-677
  3. Cole, L.A. and Kardana, A, (1992). Discordant results in human chorionic gonadotropin assays. Clin. Chem., 38, 263-27
  4. Cowan, D. A., Kicmn, A. T., Walker, C. J. and Wheeler, M. J. (1991). Effect of administration of human chorionic gonadotropin on criteria used to assess testosterone administration in atheletes. J. Endocrinol., 131, 147-154
  5. Hoermann, R., Spoettl, G., Moncayo, R. and Mann, K. (1990). Evidence for the presence of human chorionic gonadotropin and free beta-subunit of hCG in the human pituitary. J. Clin. Encoclinol. Metab., 71, 179-186
  6. Laidler, P., Cowan, D. A., Hider, R. C. and Kicman, A.T. (1994). New decision limits and quality control material for detecting human choriogondotropin misuse in sports. Clin. Chem., 40, 1306-1311
  7. Kerrigan, S. and Phillips Jr., W. H. (2001). Comparison of ELISAs for Opiates, Methamphetamine, Cocaine Metabolite, Benzodiazepines, Phencyclidine, and Cannabinoids in Whole Blood and Urine. Clin. Chem., 47, 540-547
  8. Thomas, C. M. G. and Segers, M. F. G. (1989). Quantification of choriogonadotropin: differential cross-reactivities of the free hCG $\beta$-subunit with eight different monoclonal antibody- based hCG and (hCG-$\beta$) sandwich type assays. Clin. Chem., 35, 1791-1792